So it suggested that inhibiting WHSC1 enzymatic activity and H3K36 methylation state to promote colon cancer cell apoptosis, might be a new approach to therapeutic CRC treatment to be achieved. The gene discussed is NSD2; the disease is malignant colon neoplasm.